Ashleigh Palmer
Chief Executive Officer, UNIGENE LABORATORIES INC.
Companies
- Provention Bio, Inc.Chief executive officer Jul 3, 2018 to Apr 27, 20231
- Provention Bio, Inc.Board member Jul 3, 2018 to Feb 14, 20231
- Provention Bio, Inc.President Jul 3, 2018 to Aug 18, 20201
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Provention Bio, Inc.0 shares2Apr 27, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 27, 2023U 2,570,050 shares of Provention Bio, Inc.2
- Feb 13, 2023Sold 25,835 shares at $10.04 of Provention Bio, Inc.3
- Feb 13, 2023Exercised options 25,835 shares at $2.50 of Provention Bio, Inc.3
- Feb 10, 2023Sold 50,000 shares at $10.11 of Provention Bio, Inc.3
- Feb 10, 2023Exercised options 50,000 shares at $2.50 of Provention Bio, Inc.3
- Jan 18, 2023Sold 24,165 shares at $10.27 of Provention Bio, Inc.4
- Jan 18, 2023Exercised options 24,165 shares at $2.50 of Provention Bio, Inc.4
- Nov 30, 2021Bought 3,750 shares at $6.66 of Provention Bio, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 14, 2023
- 4SEC EDGARForm 4 filed Jan 20, 2023
- 5SEC EDGARForm 4 filed Dec 1, 2021